Interview with Dr Sam Hupert - CEO of Pro Medicus Ltd
Filed with ASX · · 5 pages · English
Summary by 6ix AI
This filing is an interview with Dr. Sam Hupert, CEO of Pro Medicus Limited, discussing recent contract wins and the impact of AI on the company and the industry. Dr. Hupert highlights significant contracts with major healthcare systems, emphasizing their strategic importance and the company's growth in the market. The interview also addresses the company's strong pipeline and recent renewals, which challenge the notion that AI will negatively disrupt software companies. Additionally, Dr. Hupert discusses the company's implementation successes and the expected revenue growth from these contracts in the coming years.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Pro Medicus
- PME signs 7-year, A$16M contract with TidalHealth
- PME signs 7-Year A$90M Deal with Beth Israel Lahey Health
- PME signs 5-year, A$37M contract renewal with Northwestern
- PME signs 5-year, A$23M contract with University of Maryland
- Notification of buy-back - PME
Later from Pro Medicus
- PME signs 5-year, A$28M contract renewal Allegheny Health
- PME signs 5-year, A$16M contract renewal with OSU
- S&P DJI Announces June 2026 Quarterly Rebalance
- Binding HOA secured with Pro Medicus Limited
- PME signs HoA Echo IQ Finance Facility & Reseller Agreement
Follow Pro Medicus into a list and get an email when it puts out news.
Follow Pro Medicus